Live Breaking News & Updates on Precision diabetes inc
Stay updated with breaking news from Precision diabetes inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Precision Diabetes, Inc.: A New Study Shows GlycoMark is a Novel Biomarker of SGLT-2i Adherence finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
A New Study Shows GlycoMark is a Novel Biomarker of SGLT-2i Adherence streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ -- A new study indicates that the GlycoMark blood test identifies high-risk, asymptomatic patients with prediabetes, not detected by standard...
Hisense Unveiled Customized Products for the FIFA World Cup 2022â„¢, Setting Extraordinary Standard for Premium Lifestyle Experiences - PRN India News webindia123.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webindia123.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ -- Precision Diabetes, Inc. A new study recently published in Nature Metabolism shows that 1,5-anhydroglucitol (1,5-AG), a glucose-like...
New Late-Breaking Data at The American Diabetes Association Show GlycoMark® May Be an Effective Test for COVID-19 Severity prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article Share this article RALEIGH, N.C., April 15, 2021 /PRNewswire/ -- Precision Diabetes, Inc. (PDI), an emerging leader in precision diabetes diagnostics, announced results today from a study on its Precision IGT prediabetes test at the Precision Diabetes Medicine 2021 Conference, the annual research symposium of the Precision Medicine in Diabetes Initiative (PMDI) -- a joint effort of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). The study, "Serum Alpha-Hydroxybutyrate (AHB) Predicts Elevated 1-Hour Glucose Levels in Normoglycemic Patients," was designed to assess the predictive value of AHB for impaired glucose tolerance as measured by the 1-hour oral glucose tolerance test (OGTT). Utilizing a proprietary algorithm that incorporates AHB and predicts 1-hour glucose levels greater than 155 mg/dL, Precision IGT was strongly predictive of abnormalities in glucose regulation, even after controlling for known risk factors such as fasting glucose, HbA1c, age, gender, and BMI. The data also showed that Precision IGT predicted impaired early insulin response during the 1-hour OGTT even in patients with normal fasting glucose and HbA1c levels.
Precision Diabetes, Inc. (PDI) Presents Data on Precision IGT Prediabetes Test at Precision Diabetes Medicine 2021 Conference prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.